Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fortress Biotech Inc (NQ: FBIO )

3.710 USD -0.160 (-4.13%)
Official Closing Price Updated: 6:54 PM EST, Feb 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Fortress Biotech Inc

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO
From GlobeNewswire News Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)
From GlobeNewswire News Releases
Checkpoint Therapeutics to Participate in Three January 2021 Virtual Investor Conferences
From GlobeNewswire News Releases
Mustang Bio to Participate in Three January 2021 Virtual Investor Conferences
From GlobeNewswire News Releases
Fortress Biotech to Participate in Three January 2021 Virtual Investor Conferences
From GlobeNewswire News Releases
DEADLINE ALERT for FBIO, SPLK, BSX, and QIWI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
DEADLINE ALERT for YY, LRN, and FBIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline - FBIO
Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc. ("Fortress" or the "Company") (NASDAQ: FBIO) and certain of its officers. The class action, filed in... 
From PR Newswire
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Cont
From GlobeNewswire News Releases
FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021
From GlobeNewswire News Releases
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the F
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fortress Biotech, Inc. ("Fortress" or "the Company") (NASDAQ: FBIO) for... 
From PR Newswire
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action - FBIO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the "Class... 
From Business Wire News Releases
FBIO, NAK & SPLK Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)
From GlobeNewswire News Releases
FBIO DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO
From GlobeNewswire News Releases
DEADLINE ALERT for YY, LRN, and FBIO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
FBIO DEADLINE: Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Fortress Biotech, Inc. – FBIO
From GlobeNewswire News Releases
Fortress Biotech's Series A Preferred Stock Shares Cross 12% Yield Mark
In trading on Wednesday, shares of Fortress Biotech Inc's 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) were yielding above the 12% mark based on its monthly dividend... 
Tags Stocks
From Market News Video
LEADING ROSEN LAW FIRM Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIO
From GlobeNewswire News Releases
IMPORTANT DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO
From GlobeNewswire News Releases
DEADLINE ALERT for FBIO, SPLK, BSX, and QIWI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors
Trial underway at City of Hope to evaluate safety and feasibility of administering therapy in patients with brain tumors such as glioblastoma, ependymoma or medulloblastoma 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO
From GlobeNewswire News Releases
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)
Law Offices of Howard G. Smith reminds investors of the upcoming January 26, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Fortress Biotech, Inc.... 
From PR Newswire
Are You An Investor Who Has Lost Money In K12 or Fortress Biotech? Kehoe Law Firm, P.C. Class Action Investigations
From GlobeNewswire News Releases
Avenue Therapeutics Announces Publication of Tramadol Non-Medical Use in Four European Countries: A Comparative Analysis
From GlobeNewswire News Releases
Avenue Therapeutics Announces Publication of Real-World Data on Nonmedical Use of Tramadol in ASI-MV Network
From GlobeNewswire News Releases
80 Biggest Movers From Yesterday
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 473.7% to close at $33.96 on Thursday. Scopus BioPharma’s ... 
Tags Prescience Point BRPA ENLV
From Benzinga
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Fir
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the "Class... 
From PR Newswire
Why Fortress Biotech Stock Jumped Today
One of the company's subsidiaries announced some good news today. 
Tags FBIO ATXI Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.